Search research articles
Contact Us
Filters
Showing results (501-510 of 574) with videos related to
Page
of 58
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophy
Susanne May, Sid Gilman, B Brooke Sowell, et al.
Parkinsonism & Related Disorders
|
December 28, 2024
Factor analysis and clustering of motor and psychiatric dimensions in idiopathic blepharospasm
Angelo F Gigante, Mark Hallett, Hyder A Jinnah, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 28, 2013
Designing clinical trials for dystonia
Wendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 19, 2007
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy
Laurie J Ozelius, Tatiana Foroud, Susanne May, et al.
American Journal of Human Genetics
|
October 7, 2022
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement
Shenzhao Lu, Mengqi Ma, Xiao Mao, et al.
Journal of the Neurological Sciences
|
February 1, 2022
Head tremor in cervical dystonia: Quantifying severity with computer vision
Jeanne P Vu, Elizabeth Cisneros, Ha Yeon Lee, et al.
The American Journal of Pathology
|
March 26, 2011
Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy
Yu Wang, Aneeka M Hancock, Joshua Bradner, et al.
Parkinsonism & Related Disorders
|
September 28, 2021
Diagnostic criteria for blepharospasm: A multicenter international study
Giovanni Defazio, Hyder A Jinnah, Alfredo Berardelli, et al.
JAMA Neurology
|
June 19, 2018
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial
Joseph Jankovic, Ira Goodman, Beth Safirstein, et al.
Parkinsonism & Related Disorders
|
April 13, 2017
Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial
Robert E Wharen, Michael S Okun, Barton L Guthrie, et al.
Page
of 58
Search research articles
Search
Showing results (501-510 of 574) with videos related to
Sort By:
Page
of 58
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 5, 2007
Potential outcome measures and trial design issues for multiple system atrophy
Susanne May, Sid Gilman, B Brooke Sowell, et al.
Parkinsonism & Related Disorders
|
December 28, 2024
Factor analysis and clustering of motor and psychiatric dimensions in idiopathic blepharospasm
Angelo F Gigante, Mark Hallett, Hyder A Jinnah, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
November 28, 2013
Designing clinical trials for dystonia
Wendy R Galpern, Christopher S Coffey, Alberto Albanese, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
January 19, 2007
G2019S mutation in the leucine-rich repeat kinase 2 gene is not associated with multiple system atrophy
Laurie J Ozelius, Tatiana Foroud, Susanne May, et al.
American Journal of Human Genetics
|
October 7, 2022
De novo variants in FRMD5 are associated with developmental delay, intellectual disability, ataxia, and abnormalities of eye movement
Shenzhao Lu, Mengqi Ma, Xiao Mao, et al.
Journal of the Neurological Sciences
|
February 1, 2022
Head tremor in cervical dystonia: Quantifying severity with computer vision
Jeanne P Vu, Elizabeth Cisneros, Ha Yeon Lee, et al.
The American Journal of Pathology
|
March 26, 2011
Complement 3 and factor h in human cerebrospinal fluid in Parkinson's disease, Alzheimer's disease, and multiple-system atrophy
Yu Wang, Aneeka M Hancock, Joshua Bradner, et al.
Parkinsonism & Related Disorders
|
September 28, 2021
Diagnostic criteria for blepharospasm: A multicenter international study
Giovanni Defazio, Hyder A Jinnah, Alfredo Berardelli, et al.
JAMA Neurology
|
June 19, 2018
Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti-α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial
Joseph Jankovic, Ira Goodman, Beth Safirstein, et al.
Parkinsonism & Related Disorders
|
April 13, 2017
Thalamic DBS with a constant-current device in essential tremor: A controlled clinical trial
Robert E Wharen, Michael S Okun, Barton L Guthrie, et al.
Page
of 58